3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Spondylitis, Ankylosing
1
Pituitary Neoplasms
1
Pain
1
Neoplasm, Residual
1
Inflammation
1
Breast Neoplasms
1
Arthritis, Rheumatoid
1
Arthritis, Psoriatic
1
Agnosia
1
Interventions
blinatumomab
2
Carboplatin
2
venetoclax
1
treosulfan
1
flumatinib
1
fludarabine phosphate
1
anlotinib
1
aflutinib
1
Whole-Body Irradiation
1
Tyrosine Kinase Inhibitors
1
Peripheral Blood Stem Cell Transplantation
1
Neoadjuvant Therapy
1
Maintenance
1
Interferon alpha-2
1
Inotuzumab Ozogamicin
1
Injections
1
Immunotherapy
1
Drug Therapy
1
Docetaxel
1
Decitabine
1
Cytarabine
1
Cyclophosphamide
1
Chemotherapy, Adjuvant
1
Carmustine
1
Busulfan
1
Bortezomib
1
Blood Specimen Collection
1
Azacitidine
1
Anti-Inflammatory Agents, Non-Steroidal
1
Aminolevulinic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Neoplasm, Residual
×
Anti-Inflammatory Agents, Non-Steroidal
×
Clear all
NCT03330769
2019-04-17
UPSTREAM
University of Cagliari
Unknown
250 enrolled